Company
United StatesPublic company, NASDAQ: UTHRUnited Therapeutics Corporation (NASDAQ: UTHR), Durham, NC – FDA Inspections
Inspection records and compliance data for United Therapeutics Corporation in Durham, North Carolina. 6 FDA inspections on record, 1 Form 483, last inspected February 28, 2025. Publicly traded as NASDAQ: UTHR.
Company Profile
This profile covers United Therapeutics Corporation based in Durham, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 2
- NAI
- 4
- Form 483s
- 1
- Warning letters
- 0
First inspected August 2, 2012. Last inspected February 28, 2025.
Most cited issue areas
- Systems in place to comply with verification requirements1 inspection
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 28, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1262208 |
| May 3, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1055690 |
| February 24, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1012021 |
| August 21, 2015 | VAI | Human Drugs · Drug Quality Assurance | 939240 |
| September 27, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 850574 |
| August 2, 2012 | NAI | Human Drugs · Drug Quality Assurance | 804190 |
FDA documents
Form 483s (1)
Other FDA documents (1)
Other regulators (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
United Therapeutics Corporation
Stock ticker
UTHR
Exchange
NASDAQ
Share price
$593.31
Market cap
$25.3B
Price as of
November 13, 2026
FEI Number
3003825766
Address
55 Tw Alexander Dr, Durham, North Carolina 27709, United States
Country
United States
ID: 5f83ecf2-e9e1-408a-9a1b-b381eac864a1